Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Atems Logo
Atems Growth Score
85
CB Rank
666952
Heat Score
70
Atems is a regeneration therapy company that develops regenerative medicine and biomedical devices.
Founded
obfuscation
Private Seoul, Seoul-t'ukpyolsi, South Korea www.atems.co.kr
Medical
Medical Device
Product Research
Therapeutics
Overview

Atems
Growth Score
85
Heat Score
70

Growth Score85
0 pts
in past quarter
Heat Score 70
4 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Atems

CB Rank
666952
Atems is a regeneration therapy company that develops regenerative medicine and biomedical devices.
Founded
obfuscation
Private Seoul, Seoul-t'ukpyolsi, South Korea www.atems.co.kr
Medical
Medical Device
Product Research
Therapeutics

Details

Legal Name Atems Co., Ltd.
Operating Status Active
Company Type For Profit
Phone Number +82 02 401 7943
Contact Email info@atems.co.kr
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

A-Paste-C
A regenerative medicine product designed to treat cartilage defects by promoting tissue regeneration.
A-Paste-D
A regenerative medicine formulation aimed at cartilage regeneration and repair of cartilage defects.

Research & Development

Atems is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
News

News and Press

News•Jun 13, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 26, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

847
-10.18%
 in past month

Active Website Tech Count

15Atems is actively using 15 technologies for its website, according to BuiltWith. These include SPF, SSL by Default, and  Common Crawl.

Total IP

4The intellectual property of Atems includes 4 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Atems's headquarters? Atems is located in Seoul, Seoul-t'ukpyolsi, South Korea.Who are Atems's competitors? Alternatives and possible competitors to Atems may include S.Biomedics, TissueGene, and  Corestem Chemon.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(f7db04b 1)
|